Furthermore, these findings suggest that optimally timed and targeted anti-inflammatory interventions such as those with anti-IL-7, anti-TNF-α, and anti-IFN-γ biologicals may reduce or prevent neurodegeneration, including white matter, in the early stages of AD. This evidence concerns the gene TNF and Alzheimer disease.